Wiendl H - Search Results

1

L-selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients.

Schwab N, Schneider-Hohendorf T, Posevitz V, Breuer J, Göbel K, Windhagen S, Brochet B, Vermersch P, Lebrun-Frenay C, Posevitz-Fejfár A, Capra R, Imberti L, Straeten V, Haas J, Wildemann B, Havla J, Kümpfel T, Meinl I, Niessen K, Goelz S, Kleinschnitz C, Warnke C, Buck D, Gold R, Kieseier BC, Meuth SG, Foley J, Chan A, Brassat D, Wiendl H. Schwab N, et al. Among authors: wiendl h. Neurology. 2013 Sep 3;81(10):865-71. doi: 10.1212/WNL.0b013e3182a351fb. Epub 2013 Aug 7. Neurology. 2013. PMID: 23925765

2

GluR3 antibodies: prevalence in focal epilepsy but no specificity for Rasmussen's encephalitis.

Wiendl H, Bien CG, Bernasconi P, Fleckenstein B, Elger CE, Dichgans J, Mantegazza R, Melms A. Wiendl H, et al. Neurology. 2001 Oct 23;57(8):1511-4. doi: 10.1212/wnl.57.8.1511. Neurology. 2001. PMID: 11673604

3

Disease-modifying therapies in multiple sclerosis: an update on recent and ongoing trials and future strategies.

Wiendl H, Kieseier BC. Wiendl H, et al. Expert Opin Investig Drugs. 2003 Apr;12(4):689-712. doi: 10.1517/13543784.12.4.689. Expert Opin Investig Drugs. 2003. PMID: 12665424 Review.

4

Basic and escalating immunomodulatory treatments in multiple sclerosis: current therapeutic recommendations.

Multiple Sclerosis Therapy Consensus Group (MSTCG); Wiendl H, Toyka KV, Rieckmann P, Gold R, Hartung HP, Hohlfeld R. Multiple Sclerosis Therapy Consensus Group (MSTCG), et al. Among authors: wiendl h. J Neurol. 2008 Oct;255(10):1449-63. doi: 10.1007/s00415-008-0061-1. Epub 2008 Oct 29. J Neurol. 2008. PMID: 19005625

5

CD8+ T-cell clones dominate brain infiltrates in Rasmussen encephalitis and persist in the periphery.

Schwab N, Bien CG, Waschbisch A, Becker A, Vince GH, Dornmair K, Wiendl H. Schwab N, et al. Among authors: wiendl h. Brain. 2009 May;132(Pt 5):1236-46. doi: 10.1093/brain/awp003. Epub 2009 Jan 29. Brain. 2009. PMID: 19179379

6

PD-1 regulates neural damage in oligodendroglia-induced inflammation.

Kroner A, Schwab N, Ip CW, Leder C, Nave KA, Mäurer M, Wiendl H, Martini R. Kroner A, et al. Among authors: wiendl h. PLoS One. 2009;4(2):e4405. doi: 10.1371/journal.pone.0004405. Epub 2009 Feb 6. PLoS One. 2009. PMID: 19197390 Free PMC article.

7

Intercellular exchanges of membrane fragments (trogocytosis) between human muscle cells and immune cells: a potential mechanism for the modulation of muscular immune responses.

Waschbisch A, Meuth SG, Herrmann AM, Wrobel B, Schwab N, Lochmüller H, Wiendl H. Waschbisch A, et al. Among authors: wiendl h. J Neuroimmunol. 2009 Apr 30;209(1-2):131-8. doi: 10.1016/j.jneuroim.2009.02.005. Epub 2009 Mar 9. J Neuroimmunol. 2009. PMID: 19269695

8

Recent clinical trials and future therapies.

Meuth SG, Kleinschnitz C, Wiendl H. Meuth SG, et al. Among authors: wiendl h. J Neurol. 2008 Dec;255 Suppl 6:93-6. doi: 10.1007/s00415-008-6017-7. J Neurol. 2008. PMID: 19300967 Review.

9

T cell suppression by naturally occurring HLA-G-expressing regulatory CD4+ T cells is IL-10-dependent and reversible.

Huang YH, Zozulya AL, Weidenfeller C, Schwab N, Wiendl H. Huang YH, et al. Among authors: wiendl h. J Leukoc Biol. 2009 Aug;86(2):273-81. doi: 10.1189/jlb.1008649. Epub 2009 Apr 28. J Leukoc Biol. 2009. PMID: 19401389

10

Antigen-specific blockade of lethal CD8 T-cell mediated autoimmunity in a mouse model of multiple sclerosis.

Na SY, Eujen H, Göbel K, Meuth SG, Martens K, Wiendl H, Hünig T. Na SY, et al. Among authors: wiendl h. J Immunol. 2009 May 15;182(10):6569-75. doi: 10.4049/jimmunol.0804200. J Immunol. 2009. PMID: 19414812

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

749 results

Search Page

Filters